BENECCHI CHRISTOPHER (Chief Commercial Officer) reported 2 transactions at SAGE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/31/2025ACC: 0000950170-25-100689
Officer· Chief Commercial Officer
Since Sep 2021
-116.93K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
116.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−28.05K
Price / share
—
Trade value
—
% of position
New position
7/31/2025
28.05K→0.00
Common Stock
Direct
Shares
−36.38K
Price / share
—
Trade value
—
% of position
New position
7/31/2025
36.38K→0.00
Total
Net shares
−64.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2025 | D · Disposition | −28.05K | — | — | New position | 28.05K | 0.00 |
| Common Stock Direct | 7/31/2025 | D · Disposition | −36.38K | — | — | New position | 36.38K | 0.00 |
| Total | −64.43K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
6.05
Held after
0.00
Exercisable
—
7/31/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
6.97
Held after
0.00
Exercisable
—
7/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 7/31/2025 | D · Disposition | −12.50K | 6.05 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock40K shares | 7/31/2025 | D · Disposition | −40K | 6.97 | — | 0.00 |